Mega Doctor News
Healthy volunteers in Philadelphia and Kansas City, Missouri, will begin to test an experimental coronavirus vaccine starting this week.
The small Pennsylvania-based biotech Inovio Pharmaceuticals received regulatory clearance to begin testing. The Bill and Melinda Gates Foundation, along with other nonprofits, have poured funding into Inovio’s vaccine project.
The biotech expects to have early safety data by late summer and is aiming to produce 1 million doses by the end of 2020.
A small Pennsylvania biotech company is planning to start injecting healthy volunteers with a potential coronavirus vaccine, after receiving regulatory clearance to start clinical testing.
Researchers plan to dose the first person Monday. The experimental vaccine was developed by Inovio Pharmaceuticals, with the effort receiving funding from the Bill and Melinda Gates Foundation and the Coalition for Epidemic Preparedness Innovations.
Follow the link for more information